<DOC>
	<DOCNO>NCT02002104</DOCNO>
	<brief_summary>The replacement autologous blood vessel artificial graft urgently need clinical application . Expanded polytetrafluoroethylene ( ePTFE ) graft clinically use artificial blood vessel chemical mechanical stability . But , use arteriovenous ( AV ) graft haemodialysis , small diameter ePTFE graft high failure rate 40 % three year vivo functional lack intact endothelial cell layer . Here developed two-step modification include chemical etch plasma activation enhance hydrophilicity ePTFE . Peptide motif ( eg . cyclic RRE , RGD ) know bind integrins endothelial cell immobilize ePTFE graft . Functional peptide immobilization significantly increase adherence growth HUVEC cell ePTFEs . Patch ePTFE implantation pig 's descending aorta use evaluate vivo endothelialization modify ePTFE graft . At 28 day implantation , newly form endothelial layer peptide-immobilized ePTFE graft demonstrate SEM histological analysis . These preliminary data show potential grow intact endothelial layer improve patency rate modify ePTFE graft .</brief_summary>
	<brief_title>Endothelialized ePTFE Graft Nanobiotechnology</brief_title>
	<detailed_description />
	<criteria>Obtained peripheral blood leukocyte thick liquid ( Hsinchu Blood Center , Taiwan Blood Services Fundation ) Times sample 20 ~ 40ml / time , 2 3 time / month</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Expanded polytetrafluoroethylene ( ePTFE )</keyword>
</DOC>